The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

E.I. Ryabova

Federal State Budget Institution «National Research Center for Epidemiology and Microbiology Named After Honorary Academician N.F. Gamaleya»;
Moscow State Academy of Veterinary Medicine and Biotechnology named after K.I. Scriabin

A.A. Derkaev

Federal State Budget Institution «National Research Center for Epidemiology and Microbiology Named After Honorary Academician N.F. Gamaleya»

N.V. Pimenov

Moscow State Academy of Veterinary Medicine and Biotechnology named after K.I. Scriabin

I.B. Esmagambetov

Federal State Budget Institution «National Research Center for Epidemiology and Microbiology Named After Honorary Academician N.F. Gamaleya»

Use of recombinant adeno-associated virus for passive immunization and protection against infectious diseases

Authors:

E.I. Ryabova, A.A. Derkaev, N.V. Pimenov, I.B. Esmagambetov

More about the authors

Views: 306

Downloaded: 0

To cite this article:

Ryabova EI, Derkaev AA, Pimenov NV, Esmagambetov IB. Use of recombinant adeno-associated virus for passive immunization and protection against infectious diseases. Molecular Genetics, Microbiology and Virology. 2024;42(1):25‑33. (In Russ.)
https://doi.org/10.17116/molgen20244201125

Recommended articles:
Multiple scle­rosis and mela­noma. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(10):123-128
Adve­rse peri­natal outcomes in COVID-19. Analysis of a series of clinical obse­rvations. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):86-90

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.